If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
802.00    -2.00 (-0.25%)
Bid:
810.00
Ask:
820.00
Spread: 10.00 (1.235%)
Market Cap: £369.69m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition and Trading Update

5 Jun 2013 07:00

RNS Number : 2950G
Porvair PLC
05 June 2013
 

For immediate release 5 June 2013

 

Porvair plc ("Porvair" or "The Group")

 

Acquisition and Trading Update

 

Porvair, the specialist filtration and environmental technologies group, today announces the acquisition of the business of Eisenmann Metallurgical LLC and issues a trading update ahead of the publication of its interim results for the six months ended 31 May 2013 on 24 June 2013.

 

The Group's Microfiltration division has acquired the goodwill, business and trading assets of Eisenmann Metallurgical LLC, trading as Chand Eisenmann Metallurgical ("CEM"), for a total consideration of US$5.5 million in cash and loans. CEM designs and manufactures specialist filters from a facility in Caribou, Maine. There is a good commercial fit between CEM and Porvair's existing product portfolio. With clear cross-selling opportunities, the combined business is well positioned to accelerate its rate of growth in the US. The transaction is expected to be immediately earnings accretive.

 

The Group has started 2013 well and expects to report interim profits well ahead of 2012. Several major contracts were announced earlier in the year and will support Group performance over the next few years. All are on schedule and have begun to contribute to results. Group revenue is expected to be around 7% ahead of the first six months of 2012 at constant currency rates. Order books are strong in Microfiltration and market share gains continue to be made in Metals Filtration.

 

An analyst briefing will be held at 9.30 a.m. at Buchanan, 107 Cheapside, London, EC2V 6DN on the day of the interim results, Monday 24 June 2013.

 

Commenting on the acquisition and trading, Ben Stocks, Chief Executive, said:

 

"CEM is a highly complementary bolt-on acquisition which broadens our product range, geographic spread and materials expertise. Its staff, based in Caribou, Maine, are skilled and highly experienced and are warmly welcomed to the Group. There are many cross-selling opportunities apparent in this transaction and we plan to invest in the Caribou facility over the next 12 months to accommodate the expected growth.

 

Trading in the first half of 2013 has been satisfactory, and the prospects for the second half; supported by our order books, recent large engineering contracts, and the CEM acquisition; are good."

 

For more information, contact:

 

Porvair plc

Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500

Buchanan

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

www.buchanan.uk.com

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSANROBANRAR
Date   Source Headline
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.